HOTH Projected Dividend Yield
Hoth Therapeutics Inc ( NASDAQ : HOTH )Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); a treatment for traumatic brain injury and ischemic stroke (HT-TBI) and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). It also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for acne as well as inflammatory bowel diseases (HT-003). 20 YEAR PERFORMANCE RESULTS |
HOTH Dividend History Detail HOTH Dividend News HOTH Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |